Search hospitals > Wisconsin > Schofield
Diagnostic and Treatment Center
Claim this profileSchofield, Wisconsin 54476
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Lymphoma
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Esophageal Cancer
101 reported clinical trials
10 medical researchers
Summary
Diagnostic and Treatment Center is a medical facility located in Schofield, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Lymphoma, Non-Small Cell Lung Cancer, Esophageal Cancer and other specialties. Diagnostic and Treatment Center is involved with conducting 101 clinical trials across 199 conditions. There are 10 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Michael Husak.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage II
Stage I
2Lung Cancer
Global LeaderStage I
Stage II
Stage IV
Top PIs
Seth O. FagbemiMarshfield Medical Center-EC Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Studies Prostate Cancer
38 reported clinical trials
83 drugs studied
Adedayo A. OnitiloMarshfield Medical Center-Marshfield2 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
27 reported clinical trials
98 drugs studied
Chady A. Leon, MDMarshfield Medical Center-Marshfield6 years of reported clinical research
Studies Lymphoma
Studies Adult T-Cell Leukemia/Lymphoma
19 reported clinical trials
57 drugs studied
Michael HusakMarshfield Medical Center-EC Cancer Center2 years of reported clinical research
Studies Breast Cancer
Studies Squamous Cell Carcinoma
16 reported clinical trials
32 drugs studied
Clinical Trials running at Diagnostic and Treatment Center
Prostate Cancer
Breast Cancer
Lung Cancer
Laryngeal Cancer
Oral Cancers
Oropharyngeal Carcinoma
Bladder Cancer
Brain Tumor
ALK Gene Rearrangement
Squamous Cell Carcinoma
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Diagnostic and Treatment Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.